Fragrance and perfume company Inter Parfums (NASDAQ:IPAR) announced better-than-expected revenue in Q1 CY2025, with sales up 4.6% year on year to $338.8 million. The company expects the full year’s revenue to be around $1.51 billion, close to analysts’ estimates. Its GAAP profit of $1.32 per share was 17.3% above analysts’ consensus estimates. Is now the time to buy Inter Parfums? Find out in our full research report. Inter Parfums (IPAR) Q1 CY2025 Highlights: Revenue: $338.8 million vs analyst estimates of $329.5 million (4.6% year-on-year growth, 2.8% beat) EPS (GAAP): $1.32 vs analyst estimates of $1.13 (17.3% beat) The company reconfirmed its revenue guidance for the full year of $1.51 billion at the midpoint EPS (GAAP) guidance for the full year is $5.35 at the midpoint, roughly in line with what analysts were expecting Operating Margin: 22.2%, up from 21% in the same quarter last year Market Capitalization: $3.63 billion Company Overview With licenses to produce colognes and perfumes under brands such as Kate Spade, Van Cleef & Arpels, and Abercrombie & Fitch, Inter Parfums (NASDAQ:IPAR) manufactures and distributes fragrances worldwide. Sales Growth A company’s long-term sales performance is one signal of its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. With $1.47 billion in revenue over the past 12 months, Inter Parfums is a small consumer staples company, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and negotiating leverage with retailers. On the bright side, it can grow faster because it has a longer list of untapped store chains to sell into. As you can see below, Inter Parfums’s sales grew at an impressive 16.3% compounded annual growth rate over the last three years. This is a great starting point for our analysis because it shows Inter Parfums’s demand was higher than many consumer staples companies.Inter Parfums Quarterly Revenue This quarter, Inter Parfums reported modest year-on-year revenue growth of 4.6% but beat Wall Street’s estimates by 2.8%. Looking ahead, sell-side analysts expect revenue to grow 4.7% over the next 12 months, a deceleration versus the last three years. This projection doesn't excite us and implies its products will see some demand headwinds. At least the company is tracking well in other measures of financial health. Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) stock benefiting from the rise of AI. Click here to access our free report one of our favorites growth stories. Story Continues Cash Is King If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills. Inter Parfums has shown robust cash profitability, driven by its attractive business model that enables it to reinvest or return capital to investors. The company’s free cash flow margin averaged 11.9% over the last two years, quite impressive for a consumer staples business.Inter Parfums Trailing 12-Month Free Cash Flow Margin Key Takeaways from Inter Parfums’s Q1 Results It was encouraging to see Inter Parfums beat analysts’ revenue expectations this quarter. We were also happy its EPS outperformed Wall Street’s estimates. Overall, this print had some key positives. The market seemed to be hoping for more, and the stock traded down 1.7% to $108.50 immediately following the results. Is Inter Parfums an attractive investment opportunity right now? If you’re making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it’s free. View Comments
Inter Parfums (NASDAQ:IPAR) Beats Q1 Sales Targets
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...